Article
Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.
Antiviral research - 1 Jan 2009
Deyde Varough M, Okomo-Adhiambo Margaret, Sheu Tiffany G, Wallis Teresa R, Fry Alicia, Dharan Nila, Klimov Alexander I, Gubareva Larisa V
Abstract excerpt
Pyrosequencing has been successfully used to monitor resistance in influenza A viruses to the first class of anti-influenza drugs, M2 blockers (adamantanes). In contrast to M2 blockers, resistance to neuraminidase (NA) inhibitors (NAIs) is subtype- and drug-specific. Here, we designed a pyrosequencing assay for detection of the most commonly reported mutations associated with resistance to NAIs, a newer class of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
